Earnings Call · Q2 FY2023·2023-08-08

Q2 23EPS +100.00%*·Rev n/aQ1 23EPS +71.43%·Rev n/aQ4 22EPS +90.00%·Rev n/aQ3 22EPS +8.33%·Rev n/a⚠ consensus missing

Orthofix Medical Inc. OFIX

Louisa Smith — Investor Relations or Communications

Keith Valentine — President and Chief Executive Officer

John Bostjancic — Chief Financial Officer

+13.3%1d on move date+14.0% vs SPY3d+10.9%5d+4.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more OFIX calls or request research access.

More OFIX calls Browse calls Request research access